[Thrombocytosis and essential thrombocythemia in childhood]

V Mialou1, S Kagialis-Girard, C Galambrun

  • 1Service d'hématologie pédiatrique, hôpital Debrousse, 27, rue Soeur-Bouvier, 69005 Lyon, France. valerie.mialou@chu-lyon.fr

Insights

Secondary thrombocytosis is common in children, often caused by other conditions. This article guides diagnosis and recommends essential biological tests for pediatric thrombocytosis.

Area of Science:

  • Pediatric Hematology
  • Oncology
  • Clinical Pathology

Context:

  • Thrombocytosis, elevated platelet count, is a frequent finding in pediatric patients.
  • Secondary thrombocytosis, reactive to other conditions, is more common than primary forms.
  • Primary thrombocytosis in children can be inherited (familial) or acquired (essential thrombocythemia).

Purpose:

  • To provide diagnostic guidance for pediatric thrombocytosis.
  • To recommend appropriate biological tests for evaluating thrombocytosis in children.
  • To differentiate between secondary and primary causes of elevated platelet counts in pediatric cases.

Summary:

  • This review focuses on the diagnostic approach to thrombocytosis in children.
  • It distinguishes between secondary thrombocytosis, common and multifactorial, and rare primary forms (essential thrombocythemia, familial).
  • Key biological investigations are suggested to aid in accurate diagnosis and management.

Impact:

  • Aids clinicians in the timely and accurate diagnosis of pediatric thrombocytosis.
  • Facilitates appropriate patient management by identifying underlying causes.
  • Contributes to the understanding of thrombocytosis epidemiology and diagnostics in pediatric populations.

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...